Van Dijck R, Schnog J-JB, te Boekhorst PA. Moving forward from spleen response as an endpoint in randomized controlled trials in myelofibrosis. haematol [Internet]. 2026Feb.1 [cited 2026Feb.4];111(2):470-8. Available from: https://haematologica.org/article/view/12296